当前位置:首页 - 行情中心 - 昭衍新药(603127) - 财务分析

昭衍新药

(603127)

  

流通市值:118.78亿  总市值:141.20亿
流通股本:6.30亿   总股本:7.49亿

昭衍新药(603127)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.74亿元,每股收益-0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益799083.46万元,未分配利润197412.01万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产952518.48万元,负债153435.02万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,335,156,050.4849,356,544.11324,809,103.672,376,486,797.1
营业总成本1,227,734,251.03753,062,458.9293,294,646.961,622,010,226.39
营业利润-69,661,013.72-177,154,741.3-293,008,274.73507,096,321.21
利润总额-69,892,269.79-177,351,107.31-293,130,015.64506,950,437.23
净利润-74,244,009.94-172,238,316.14-273,363,603.07391,552,561.64
其他综合收益-4,859,185.753,024,917.86863,793.544,960,762.67
综合收益总额-79,103,195.69-169,213,398.28-272,499,809.53396,513,324.31
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计5,334,112,028.965,492,884,034.546,971,164,178.587,121,967,340.11
非流动资产合计4,191,072,779.024,168,389,654.142,762,090,308.722,905,192,290.36
资产总计9,525,184,807.989,661,273,688.689,733,254,487.310,027,159,630.47
流动负债合计1,298,706,870.561,518,194,812.491,502,563,540.441,467,365,088.64
非流动负债合计235,643,339.19227,837,447.75236,962,783.63278,754,126.75
负债合计1,534,350,209.751,746,032,260.241,739,526,324.071,746,119,215.39
归属于母公司股东权益合计8,002,435,682.27,916,012,413.27,993,144,600.588,279,315,724.35
股东权益合计7,990,834,598.237,915,241,428.447,993,728,163.238,281,040,415.08
负债和股东权益合计9,525,184,807.989,661,273,688.689,733,254,487.310,027,159,630.47
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,367,691,390.73919,139,371.69492,589,961.12,433,306,501.42
经营活动现金流出小计1,175,365,681.39761,422,728.38372,636,441.791,810,431,362.98
经营活动产生的现金流量净额192,325,709.34157,716,643.31119,953,519.31622,875,138.44
投资活动现金流入小计2,508,098,115.211,914,486,106.33111,453,520.72623,903,128.48
投资活动现金流出小计3,458,148,881.922,660,158,066.46179,015,819.37939,332,589.88
投资活动产生的现金流量净额-950,050,766.71-745,671,960.13-67,562,298.65-315,429,461.4
筹资活动现金流入小计----
筹资活动现金流出小计248,828,091.97107,250,255.9937,928,364.49361,677,897.08
筹资活动产生的现金流量净额-248,828,091.97-107,250,255.99-37,928,364.49-361,677,897.08
汇率变动对现金及现金等价物的影响-6,969,366.76-246,310.23-2,795,727.798,409,667.48
现金及现金等价物净增加额-1,013,522,516.1-695,451,883.0411,667,128.38-45,822,552.56
期末现金及现金等价物余额1,840,124,511.872,158,195,144.932,865,314,156.352,853,647,027.97
最新报告期:2024-11-03
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国泰君安丁丹0.080.520.682024-11-03
中信证券陈竹0.120.530.772024-10-08
国信证券张佳博,彭思宇0.120.400.452024-09-13
中金公司张琎0.250.45--2024-09-02
TOP↑